MusclePharm EBITDA
What is the EBITDA of MusclePharm?
The EBITDA of MusclePharm Corp. is -$11.38
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Consumer Staples sector on OTC compared to MusclePharm
What does MusclePharm do?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Companies with ebitda similar to MusclePharm
- Guru Online () has EBITDA of -HKD$11.45
- The Real Brokerage Inc has EBITDA of -$11.45
- Phunware Inc has EBITDA of -$11.44
- Marin Software Inc has EBITDA of -$11.42
- Delta 9 Cannabis has EBITDA of -CAD$11.41
- Skye Bioscience has EBITDA of -$11.38
- MusclePharm has EBITDA of -$11.38
- InfraStrata Plc has EBITDA of -£11.38
- Camurus AB (publ) has EBITDA of -kr11.38
- Orbite Technologies has EBITDA of -CAD$11.38
- NorZinc has EBITDA of -CAD$11.37
- Clearfield Inc has EBITDA of -$11.37
- Euro Manganese has EBITDA of -CAD$11.34